Logo image of VM.CA

VOYAGEUR PHARMACEUTICALS LTD (VM.CA) Stock Overview

TSX-V:VM - CA92918C1014 - Common Stock

0.165 CAD
0 (0%)
Last: 8/29/2025, 7:00:00 PM

VM.CA Key Statistics, Chart & Performance

Key Statistics
52 Week High0.36
52 Week Low0.04
Market Cap28.16M
Shares170.66M
Float154.46M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.01
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO05-18 2012-05-18
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


VM.CA short term performance overview.The bars show the price performance of VM.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5

VM.CA long term performance overview.The bars show the price performance of VM.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150 200 250

The current stock price of VM.CA is 0.165 CAD. In the past month the price decreased by -5.71%. In the past year, price increased by 230%.

VOYAGEUR PHARMACEUTICALS LTD / VM Daily stock chart

About VM.CA

Company Profile

VM logo image Voyageur Pharmaceuticals Ltd. engages in exploring and development of barite, iodine, and fullerene Active Pharmaceutical Ingredient (API) minerals. The company is headquartered in Calgary, Alberta. The company went IPO on 2012-05-18. The company focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

Company Info

VOYAGEUR PHARMACEUTICALS LTD

Dome Tower 800, 333 7 Ave. S.W.

Calgary ALBERTA T2G 2B3 CA

CEO: Brent Willis

Employees: 0

VM Company Website

VM Investor Relations

Phone: 14039235944

VOYAGEUR PHARMACEUTICALS LTD / VM.CA FAQ

What is the stock price of VOYAGEUR PHARMACEUTICALS LTD today?

The current stock price of VM.CA is 0.165 CAD.


What is the ticker symbol for VOYAGEUR PHARMACEUTICALS LTD stock?

The exchange symbol of VOYAGEUR PHARMACEUTICALS LTD is VM and it is listed on the TSX Venture Exchange exchange.


On which exchange is VM.CA stock listed?

VM.CA stock is listed on the TSX Venture Exchange exchange.


What is VOYAGEUR PHARMACEUTICALS LTD worth?

VOYAGEUR PHARMACEUTICALS LTD (VM.CA) has a market capitalization of 28.16M CAD. This makes VM.CA a Nano Cap stock.


How many employees does VOYAGEUR PHARMACEUTICALS LTD have?

VOYAGEUR PHARMACEUTICALS LTD (VM.CA) currently has 0 employees.


What are the support and resistance levels for VOYAGEUR PHARMACEUTICALS LTD (VM.CA) stock?

VOYAGEUR PHARMACEUTICALS LTD (VM.CA) has a support level at 0.16 and a resistance level at 0.17. Check the full technical report for a detailed analysis of VM.CA support and resistance levels.


Should I buy VOYAGEUR PHARMACEUTICALS LTD (VM.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VOYAGEUR PHARMACEUTICALS LTD (VM.CA) stock pay dividends?

VM.CA does not pay a dividend.


What is the Price/Earnings (PE) ratio of VOYAGEUR PHARMACEUTICALS LTD (VM.CA)?

VOYAGEUR PHARMACEUTICALS LTD (VM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).


VM.CA Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to VM.CA. When comparing the yearly performance of all stocks, VM.CA is one of the better performing stocks in the market, outperforming 94.25% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

VM.CA Financial Highlights

Over the last trailing twelve months VM.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -22.69% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -73.87%
ROE -238.54%
Debt/Equity 0.04
Chartmill High Growth Momentum
EPS Q2Q%46.88%
Sales Q2Q%N/A
EPS 1Y (TTM)-22.69%
Revenue 1Y (TTM)N/A

VM.CA Forecast & Estimates


Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

VM.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners9.25%
Short Float %N/A
Short RatioN/A